Recon: CDC pulls COVID vaccine recommendation for healthy children, pregnant women; Eli Lilly to purchase SiteOne in deal valued up to $1B

• US drops COVID vaccine recommendations for healthy children, pregnant women (Reuters) (CNN)
• At a major genome editing summit, spotlight turns to the value of human life (STAT)
• Colorado Drug Pricing Board Hits Back at Amgen Legal Challenge (Bloomberg Law)
• US FDA approves use of Sanofi's meningococcal vaccine in infants (Reuters)
• Eli Lilly to buy privately held SiteOne in deal worth up to $1 billion (Reuters)

• I’m a dentist from India. The fluoride debate in the U.S. horrifies me (STAT)
• Majority of medical equipment supplies at 'stock zero' in Gaza, WHO says (Reuters)
• Sanofi exploring vaccine production in Vietnam with local partner (Reuters)
• Commission’s Flora Giorgio Says Simplification And Safety Are Key In Evolving EU Regs (MedTech Insight)
• German Bionic Launches ‘Strongest Exoskeleton To Date’ (MedTech Insight)
• EU To Track Decentralized Clinical Trials In CTIS To Support Innovation (Pink Sheet)
• Why Hympavzi Secured English Funding For Hemophilia B But Not Hemophilia A (Pink Sheet)

• Participant in Rocket Pharmaceuticals gene therapy study dies (STAT)
• Longevity seekers misunderstand a fundamental truth about biology (STAT)
• Roche extends trials of promising antibiotic against resistant superbug (The Financial Times)
• Blackstone's GRIN inks epilepsy licensing deal with Angelini, closes $140M Series D (Endpoints)
• Gilgamesh’s short-acting psychedelic drug shows rapid effect in Phase 2 depression study (Endpoints)
• ITM reveals up to $262M debt financing; Caris Life Sciences to go public (Endpoints)
• Biogen taps City Therapeutics in RNAi deal worth up to $1B (Endpoints)
• Prothena’s amyloidosis drug flops again, spending and staff cuts are on the way (Endpoints)
• Syndeio debuts with $90M+ to bring together synapse repair drugs (Endpoints)
• Investors pump $130M into protein degrader startup GlycoEra (Endpoints)
• Exclusive: Toronto biotech ProteinQure nears the clinic with peptide platform as it raises $11M Series A (Endpoints)

• The AI threat to public health no one is thinking about: a fake bioterrorist attack (STAT)
• Brooklyn Health raises $6.5M to standardize mental health assessment (Endpoints)
• BD recalls esophagogastric tubes linked to 2 serious injuries, 1 death (MedTech Dive)
• Medtronic To Spin Out Diabetes Unit As New Products Solidify Turn-Around Story (MedTech Insight)
• Medtronic Eyes Up to $350M Tariff Hit in FY26, Leans On Cost Controls And Pricing Strategy (MedTech Insight)

• Swedish Food Agency Publishes 2019-2023 Analysis of Foodborne Illnesses (Food Safety)

• To address the pharmacy crisis, doctors should dispense some drugs (STAT)
• A Harvard scientist built a database of 2,100 NIH grant terminations. Then his own funding was cut (STAT)
• STAT Plus:In its flagship journal, the CDC keeps publishing papers after firing scientists who made the research possible (STAT)
• What Baby KJ means for the CRISPR gene editing industry (STAT)